For years, injectable medications like Wegovy® (semaglutide) and Mounjaro® (tirzepatide) have dominated the conversation around medical weight management. But recently, attention turned to a new oral pill from Viking Therapeutics (VK2735), which showed impressive early results — and raised important questions.
The Promise: Up to 12% Weight Loss in Just 13 Weeks
In clinical trials, Viking’s pill helped participants lose as much as 12.2% of their body weight in 13 weeks. That’s a dramatic reduction for a pill-based treatment, especially compared to traditional weight-loss drugs. Like the injectables, VK2735 works by mimicking hormones that regulate appetite and blood sugar.
The idea of simply taking a daily pill — no injections, no refrigeration — is understandably exciting. Oral treatments may also be more accessible for people hesitant about self-injections.
The Challenge: Why Many Patients Dropped Out
But the study also revealed a major challenge. Nearly 20% of participants discontinued treatment due to side effects, compared to 13% in the placebo group. The most common issues were gastrointestinal (GI) side effects, including nausea, vomiting, and diarrhea.
For many patients, these side effects can feel overwhelming, leading to inconsistent use or stopping the medication altogether. This highlights an important truth in medical weight management: the most effective treatment is the one you can safely stay on long-term.
What This Means for Patients Today
While Viking’s pill is still in development — and likely years away from approval — it underscores how rapidly the field of obesity medicine is evolving. The future may bring multiple new oral therapies, but today, the most proven, safe, and effective options remain the FDA-approved GLP-1 and GLP-1/GIP injectables like Ozempic®, Wegovy®, and Zepbound®.
At Achieve Health & Weight Loss, we follow these developments closely. Our mission is to help members not just access the latest medications, but also use them safely, with physician oversight, personalized coaching, and real-time monitoring of progress.
Achieve’s Approach: Safety, Support, and Results
Unlike trends or “quick fixes,” Achieve’s program is designed for sustainable, long-term success:
- Double board-certified physician oversight in Internal Medicine and Obesity Medicine.
- Access to proven medications like Wegovy®, Ozempic®, Zepbound®, and Mounjaro®.
- A remote body-composition scale to track fat loss, not just pounds.
- 1:1 health coaching for lifestyle support, nutrition, and accountability.
- Medication titration and refills to minimize side effects and maximize results.
Our members lose an average of 20% or more of their body weight, resulting in improvements in health, confidence, and quality of life.
The Bottom Line
Viking’s oral pill is an exciting sign of what’s to come in weight-loss medicine. But for those struggling with obesity or weight-related health issues today, the best path forward is through safe, effective, and physician-guided treatments available now.
At Achieve Health & Weight Loss, we help patients make sense of all the options — present and future — while delivering real results today.
